Dr. Lal PathLabs Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dr. Lal PathLabs Ltd with three other
pharmaceutical manufacturers in Asia:
Thyrocare Technologies Ltd
sales of 3.56 billion Indian Rupees [US$49.17 million]
Ina Research Incorporation
(2.43 billion Japanese Yen [US$21.32 million]
Medical & Biological Laboratories Company Limited
based in Japan
(7.07 billion Japanese Yen [US$62.16 million]
of which 99%
was Reagent business).
Dr. Lal PathLabs Ltd reported sales of 10.57 billion Indian Rupees (US$145.85 million)
March of 2018.
increase of 15.8%
versus 2017, when the company's sales were 9.12 billion Indian Rupees.
Sales at Dr. Lal PathLabs Ltd have increased during each of the previous five years
(and since 2013, sales have increased a total of 134%).